EMERYVILLE, Calif.--(BUSINESS WIRE)--AllCells LLC, a leading global provider of human hematopoietic primary cells and services, today announced that Jack Zhai has joined the company’s executive leadership team as Vice President, Sales & Marketing. Mr. Zhai received his Ph.D. in Cell and Molecular Biology at UW-Madison. In addition, the company recently strengthened its sales force in North America, product management, and marketing team including applications scientists.
Dr. Zhai will provide executive input into enhancing the company’s commercial strategy and supporting its operational excellence. Jay Tong M.D., the company’s President & CEO commented, “Jack brings a wealth of life science industry experience to AllCells, previously serving with Millipore, Invitrogen, and Applied Biosystems in the areas of marketing, sales, and business development. I’m confident Jack will be instrumental in helping build our organization as AllCells expands its business both in the U.S. and internationally.”
“I’m extremely excited about this opportunity,” said Dr. Zhai. “AllCells has demonstrated an impressive track record of success over the past 13 years emerging as a leading provider of primary cells and related services which support the cell-based research of pharmaceutical, biotechnology, and vaccine companies worldwide. I’m eager to contribute to its continued growth and success of the business.”
About AllCells LLC
AllCells (www.AllCells.com) is a global biotechnology company founded in 1998 to provide researchers with a reliable supply of biologically relevant, consistent quality primary cells that enable the advancement of scientific research in the areas of cell biology, oncology, virology, hematology, infectious disease and stem cell research. Unlike cell lines, which are typically mutated, transformed or immortalized, primary cells retain their original phenotypes hence better reflect in vivo morphology, metabolism and growth characteristics. These attributes are especially important for in vitro research applications where in vivo-like models are critically important. By partnering with AllCells, investigators can dramatically reduce time needed to isolate cells with guaranteed consistency thereby improving the efficiency, accuracy and relevance of their research studies. AllCells is fully certified in accordance with local, state and federal requirements.